GlaxoSmithKline PLC (LSE:GSK) - Share price - Overview

Not a customer yet?

Buy shares from £4.95 with our easy-to-use SIPPs, ISAs and Dealing accounts

Find out more

Stock Report

GlaxoSmithKline PLC GSK

Last Price
£1,364.40

Day Change
9.20|0.68%

As of 23/01/2018
18:44:23 GMT | GBP
Minimum 15 Minutes Delay.

Last Close1,355.20
Day Range1,350.60 - 1,375.60
Mkt Cap67.09Bil
52-Wk Range1,270.00 - 1,724.50
Yield %5.86
ISINGB0009252882
Volume9,157,017
P/E41.19
P/S2.38
P/CF11.29

Share Price

Total Returns 23/01/2018

 Chg (%)  
More ...
GlaxoSmithKline PLC4.79 
FTSE 100 TR GBP1.96
 
Financials
201420152016
More ...
Income Statement
Turnover23,006.0023,923.0027,889.00
Operating Profit3,597.0010,322.002,598.00
Net Profit2,831.008,372.001,062.00
Reported EPS56.70172.3018.60
Balance Sheet
Current Assets13,522.0016,541.0016,496.00
Non Current Assets25,973.0036,859.0042,370.00
Total Assets40,651.0053,446.0059,081.00
Current Liabilities13,295.0013,417.0019,001.00
Total Liabilities35,715.0044,568.0054,118.00
Total Equity4,936.008,878.004,963.00
Cash Flow
Operating Cash Flow6,284.004,631.008,106.00
Net Change in Cash-1,287.001,503.00-1,164.00
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20176,992.50110.96234.9712.300.0580.005.86
20187,501.06107.85-2.8012.65-4.5280.005.86

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
12/01/2018in Lieu of DividendMr. Simon Dingemans1,334.4092012,276.00
11/01/2018in Lieu of DividendMr. Simon Dingemans1,330.8723306.00
11/01/2018in Lieu of DividendMr. Simon Dingemans1,330.601231,637.00
11/01/2018in Lieu of DividendMr. Simon Dingemans1,330.601231,637.00

Company Profile

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products.

Sector

Drug Manufacturers - Major

Market Position

6 of 1834 Companies

Index

FTSE 100 ,FTSE 350 ,FTSE Eurotop 100 ,S&P Europe 350 ,Eurotop 300

Outlook

(25/10/2017) "...we remain on course for our full-year earnings guidance, with cash generation continuing to improve"

Next Event 07/02/2018

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)12.6514.3216.98
Div Yld (E)5.864.044.04
PEG (E)-4.52-0.401.27
ROCE58.42178.5417.10
Op Mrgn25.81-7.161.92
EPS Grwth-2.805.7712.52
Dividends
PreviousLatest
More ...
Record Date11/08/1710/11/17
Ex-Div10/08/1709/11/17
Paid12/10/1711/01/18
Amnt19.0019.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanSir Philip Hampton
Chief Executive OfficerEmma Walmsley
Chief Financial OfficerMr. Simon Dingemans
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.